ProfessorRakesh Heer, BMed Sci MB BS MRCS PhD FRCS
Chair of Urology
Department of Surgery & Cancer - Faculty of Medicine
Orcid identifier0000-0003-1952-7462 (opens in a new tab)
- Chair of UrologyDepartment of Surgery & Cancer - Faculty of Medicine
- Hammersmith House, Hammersmith Campus, United Kingdom
RESEARCH
Overview
Clinical trials in kidney, bladder and prostate cancer:
Chief Investigator, NIHR FOLLOW UP; £1.9M; 2024-2028. A natural experiment comparing the clinical and cost-effectiveness of follow-up strategies after radical treatment for prostate cancer
Chief Investigator, NIHR PARTIAL; £1.9M; 2022-2027. Randomised trial of the clinical and cost effectiveness of PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma
Co-Investigator, CRUK Early Detection and Diagnosis Research PACIFIC; £1.7M; 2022-2026. Evaluating the role of fast MRI and image-fusion for detection of prostate cancer (Lead PI Ahmed)
Chief Investigator, NIHR PHOTO; £2.4M; 2014-2021. A randomised trial comparing photodynamic guided resection with standard white light surgery
Chief Investigator, NIHR VARIANT; £0.3M; 2018-2021. A trial of biomarker-driven treatment in prostate cancer
Principle investigator, NIHR BRC; £0.2M; 2018-2021. Developing biomarkers using mitochondrial DNA mutation lineage tracing for early detection of bladder cancerPrinciple investigator, Innovate UK CICERO; £0.3M; 2017-2018. AI-embedded image-enhanced video cystoscopy for a bladder cancer detection
The characterisation of human prostate stem cells:
Principle investigator, Prostate Cancer Foundation award; $1M; 2019-2021. Patient stem cell derived prostate organoids for preclinical testing and treatment stratification.
Principle investigator, Prostate Cancer Research grant; £0.5M; 2022-2025. Mapping the epigenetic evolution of prostate carcinogenesis (Epi-Evo study).
Co-investigator, Prostate Cancer Research grant; £0.5M; 2020-2024. Filling a critical knowledge gap in androgen receptor variant splicing to enable development of new prostate cancer therapies.
CRUK Clinician Scientist Fellowship; £0.8M; 2011-2016.In situ characterisation of prostate stem cell fate.
Royal College of Surgeon’s Hunterian Professorship and Medal 2010.
MRC Clinician PhD Fellow; £0.1M; 2003-2006. The role of KGF in prostatic stem cell differentiation.
Clinical trials in kidney, bladder and prostate cancer:
Chief Investigator, NIHR FOLLOW UP; £1.9M; 2024-2028. A natural experiment comparing the clinical and cost-effectiveness of follow-up strategies after radical treatment for prostate cancer
Chief Investigator, NIHR PARTIAL; £1.9M; 2022-2027. Randomised trial of the clinical and cost effectiveness of PARTIAL vs radical nephrectomy for clinically localised renal cell carcinoma
Co-Investigator, CRUK Early Detection and Diagnosis Research PACIFIC; £1.7M; 2022-2026. Evaluating the role of fast MRI and image-fusion for detection of prostate cancer (Lead PI Ahmed)
Chief Investigator, NIHR PHOTO; £2.4M; 2014-2021. A randomised trial comparing photodynamic guided resection with standard white light surgery
Chief Investigator, NIHR VARIANT; £0.3M; 2018-2021. A trial of biomarker-driven treatment in prostate cancer
Principle investigator, NIHR BRC; £0.2M; 2018-2021. Developing biomarkers using mitochondrial DNA mutation lineage tracing for early detection of bladder cancerPrinciple investigator, Innovate UK CICERO; £0.3M; 2017-2018. AI-embedded image-enhanced video cystoscopy for a bladder cancer detection
The characterisation of human prostate stem cells:
Principle investigator, Prostate Cancer Foundation award; $1M; 2019-2021. Patient stem cell derived prostate organoids for preclinical testing and treatment stratification.
Principle investigator, Prostate Cancer Research grant; £0.5M; 2022-2025. Mapping the epigenetic evolution of prostate carcinogenesis (Epi-Evo study).
Co-investigator, Prostate Cancer Research grant; £0.5M; 2020-2024. Filling a critical knowledge gap in androgen receptor variant splicing to enable development of new prostate cancer therapies.
CRUK Clinician Scientist Fellowship; £0.8M; 2011-2016.In situ characterisation of prostate stem cell fate.
Royal College of Surgeon’s Hunterian Professorship and Medal 2010.
MRC Clinician PhD Fellow; £0.1M; 2003-2006. The role of KGF in prostatic stem cell differentiation.